Morgan Levy, PGY2 Radiation Oncology Resident, Communications Chair at SWRO, ASTRO25 Social Champion, shared a post on X:
“First up NRG GU006 BALANCE trial showing significant improvement in PFS in recurrent prostate cancer with radiation and apalutamide! Also the first biomarker stratified prospectively validated use of HRT․”
More posts featuring Morgan S. Levy on OncoDaily.
